ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research

February 10, 1978